Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis
- PMID: 34338440
- DOI: 10.1002/lt.26249
Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis
Comment on
-
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis.Liver Transpl. 2021 Dec;27(12):1711-1722. doi: 10.1002/lt.26100. Epub 2021 Aug 1. Liver Transpl. 2021. PMID: 34018303 Free PMC article.
References
-
- Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020;3:e201997.
-
- Hirode G, Vittinghoff E, Wong RJ. Increasing clinical and economic burden of nonalcoholic fatty liver disease among hospitalized adults in the United States. J Clin Gastroenterol 2019;53:765‐771.
-
- Mahmud N, Halpern S, Farrell R, Ventura K, Thomasson A, Lewis H, et al. An advanced practice practitioner‐based program to reduce 30‐ and 90‐day readmissions after liver transplantation. Liver Transpl 2019;25:901‐910.
-
- Saleem S, Katragadda R, Weissman S, Bleibel W. Morbidity and mortality of infections in the cirrhotic patients: a US population‐based study. Gastroenterol Hepatol Bed Bench 2019;12:233‐238.
-
- Desai AP, Mohan P, Nokes B, Sheth D, Knapp S, Boustani M, et al. Increasing economic burden in hospitalized patients with cirrhosis: analysis of a national database. Clin Transl Gastroenterol 2019;10:e00062.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
